NASDAQ:IRIS IRIS International (IRIS) Stock Price, News & Analysis → Trump’s “Tax Free” Retirement Strategy (From Gold Safe Exchange) (Ad) Free IRIS Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Share Share Today's Range$3.40▼$3.7050-Day Range N/A52-Week Range$8.50▼$19.97Volume9,640 shsAverage Volume312,442 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get IRIS International alerts: Email Address Ad Porter & CompanyElon to Transform U.S. Economy? A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.One company holds a near-total monopoly on it. About IRIS International Stock (NASDAQ:IRIS)Mitcham Industries, Inc. is a provider of equipment to the geophysical, oceanographic and hydrographic industries. The Company operates through two segments. The Equipment Leasing segment is primarily engaged in the leasing of seismic equipment to companies in the oil and gas industry across the world. The Equipment Manufacturing and Sales segment is engaged in the design, production and sale of marine seismic equipment, and oceanographic and hydrographic equipment. Its leasing business includes Mitcham Canada ULC, Seismic Asia Pacific Pty Ltd., Mitcham Seismic Eurasia LLC, Mitcham Europe Ltd. and Mitcham Marine Leasing Pte. Ltd. The Equipment Manufacturing and Sales Segment includes its Seamap International Holdings Pte, Ltd. (Seamap) business and Klein Marine Systems, Inc. (Klein). Seamap designs, manufactures and sells a range of products for the seismic, hydrographic and offshore industries. Klein develops and manufactures high performance side scan sonar systems.Read More Ad Porter & CompanyElon to Transform U.S. Economy? A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.One company holds a near-total monopoly on it. IRIS Stock News HeadlinesMay 9, 2024 | msn.comCannes Film Festival President Iris Knobloch Addresses How Event Will Deal With Potential #MeToo AllegationsMay 9, 2024 | msn.comHow AI is Redefining Middle Eastern WarfareMay 9, 2024 | Banyan Hill Publishing (Ad)The Best AI Stock to Own in the World Today is Trading for Just $25“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.May 6, 2024 | msn.comA look inside of the Central Virginia Iris Society Show & Sale at Lewis Ginter Botanical GardenMay 6, 2024 | msn.comWho is Trent Alexander-Arnold's girlfriend? Liverpool star spotted with Hollywood star's daughterMay 5, 2024 | finance.yahoo.comIris Indie International Announces New Distribution Division and Appointment of Milena Rimassa as Its PresidentMay 5, 2024 | msn.comWho is Trent Alexander-Arnold's girlfriend? Liverpool star spotted with Hollywood star's sisterMay 5, 2024 | msn.comCan Franco-German relations be rekindled over the Ukraine war?May 9, 2024 | Banyan Hill Publishing (Ad)The Best AI Stock to Own in the World Today is Trading for Just $25“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.May 3, 2024 | msn.comTom Hollander, Niamh Algar to Star in Sky Thriller Series ‘Iris’ From ‘Luther’ CreatorMay 3, 2024 | msn.comMeryl Streep to Receive Honorary Palme d’Or at Cannes Film Festival on Opening Night (EXCLUSIVE)May 2, 2024 | yahoo.comMeryl Streep to Receive Honorary Palme d’Or in CannesMay 2, 2024 | msn.comMeryl Streep Set to Receive Cannes Honorary Palme D’OrMay 2, 2024 | msn.comTom Hollander, Niamh Algar to Star in Sky Thriller Series ‘Iris' From ‘Luther' CreatorMay 2, 2024 | msn.comTom Hollander, Niamh Algar Set to Lead ‘Luther’ Creator’s New Sky Original Drama ‘Iris’May 1, 2024 | msn.comThe Art of the Branded Mini-Doc: A Fashion Brand and a BankMay 1, 2024 | msn.comUkraine war latest: Germany delivers Skynex air defense system, Marder vehicles, ammunitionMay 1, 2024 | mirror.co.ukTrent Alexander-Arnold steps out for London stroll with Jude Law's model daughter IrisApril 30, 2024 | ca.news.yahoo.comMexico accuses Ecuador of violating international law by storming Mexican embassy in QuitoApril 30, 2024 | finance.yahoo.comIris Indie International to Host Exclusive Screening of Acclaimed SLOANE: A JAZZ SINGER Documentary at CannesApril 30, 2024 | msn.comNavigating Airport Security Just Got Easier Thanks To A New TSA PreCheck PartnershipApril 30, 2024 | msn.comUkraine Receives Advanced Military Aid Including Skynex Air Defense from GermanyApril 29, 2024 | msn.comMayor of Kingstown season 3 premieres June 2 on Paramount+April 29, 2024 | yahoo.comRussian strikes overwhelm Ukraine’s overstretched air defense amid Western aid delaysApril 27, 2024 | msn.comAre REAL IDs mandatory in NC? Are REAL IDs different than driver's licenses? What to knowApril 25, 2024 | msn.comIRIS beamline at BESSY II gets a new nanospectroscopy end stationApril 23, 2024 | msn.com$43 round-trip flights from SC: Frontier offers 1-day sale on Earth DaySee More Headlines Receive IRIS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for IRIS International and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings9/07/2016Today5/09/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorN/A Industry N/A Sub-IndustryOil & Gas Equipment & Services Current SymbolNASDAQ:IRIS CUSIP60650110 CIK319240 Webwww.proiris.com Phone+1-818-5277000FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 10 Best Cheap Stocks to Buy NowMarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.Get This Free Report Key ExecutivesRobert P. CappsCo-Chief Executive Officer and Executive Vice President -Finance and Chief Financial Officer, DirectorGuy MaldenCo-Chief Executive Officer and Executive Vice President of Marine SystemsMark A. CoxVice President - Finance and Accounting, Principal Accounting OfficerPeter H. BlumNon-Executive Independent Chairman of the BoardRobert John AlbersIndependent DirectorThomas S. GlanvilleIndependent DirectorRandal Dean LewisIndependent DirectorMarcus C. RowlandIndependent DirectorMore Executives IRIS Stock Analysis - Frequently Asked Questions How were IRIS International's earnings last quarter? IRIS International Inc (NASDAQ:IRIS) issued its quarterly earnings results on Wednesday, September, 7th. The scientific and technical instruments company reported ($0.80) earnings per share for the quarter, missing analysts' consensus estimates of ($0.49) by $0.31. The scientific and technical instruments company earned $8.70 million during the quarter, compared to analysts' expectations of $11.20 million. What other stocks do shareholders of IRIS International own? Based on aggregate information from My MarketBeat watchlists, some companies that other IRIS International investors own include Biocept (BIOC), Allena Pharmaceuticals (ALNA), Palatin Technologies (PTN), Weatherford International (WFT), Arbutus Biopharma (ABUS), AcelRx Pharmaceuticals (ACRX), Ampliphi Biosciences (APHB), ArQule (ARQL) and Arrowhead Pharmaceuticals (ARWR). This page (NASDAQ:IRIS) was last updated on 5/9/2024 by MarketBeat.com Staff From Our PartnersProof that the Musk/Bezos rivalry is about to hit a new levelInvestorPlaceDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldThe A.I. story nobody is telling you (Read ASAP)TradeSmithDems have chosen Biden replacement?Paradigm PressUrgent Nvidia WarningAltimetryTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeThe Crypto 9-5 Escape PlanCrypto 101 Media Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IRIS International Inc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.